Core Insights - The article highlights the rapid growth of the invisible orthodontics brand "Times Angel" from Wuxi, which has become a leader in the global market, supported by a robust industrial cluster in the Huishan Economic and Technological Development Zone [1][2] Group 1: Industry Development - The Huishan Life Science Industrial Park, established in 2009, focused on the niche market of "digital orthodontics" rather than following the mainstream path, leading to the introduction of Times Angel as a key enterprise [2] - The park has attracted over 30 oral health-related companies, creating a complete industrial chain covering orthodontics, implants, restorations, materials, equipment, and services, forming the only full-chain dental industry cluster in the Yangtze River Delta [2][5] Group 2: Innovation and Collaboration - Continuous innovation is driven by a collaborative ecosystem that connects clinical needs with research and development, facilitated by partnerships with top institutions like Sichuan University and Shanghai Jiao Tong University [3] - The establishment of seven innovation platforms bridges the gap between local enterprises and leading clinical resources, enhancing the effectiveness of innovation [3] Group 3: Future Vision and Ecosystem - The Huishan region aims to integrate medical technology with consumer products, creating a collective brand image of "Oral Intelligence, Huishan Selection" [4] - A systematic ecological support framework is being developed, including specialized functional areas for R&D, testing, and consumer experience, alongside initiatives to attract social capital and cultivate technical talent in the dental industry [4][5]

Core Insights - The article highlights the rapid growth of "Times Angel," a brand in the global invisible orthodontics market, originating from Wuxi Huishan, which has developed into a significant player in the industry [1] - The Huishan Economic and Technological Development Zone has evolved into a hub for over 30 dental enterprises, generating an annual output value exceeding 3 billion yuan, forming the "Yangtze River Delta Dental Valley" [1] Group 1: Industry Development - The Huishan Life Science Industrial Park, established in 2009, initially focused on the niche "digital orthodontics" sector, attracting "Times Angel" as a key enterprise for growth [3] - The park has successfully created a complete industrial chain covering orthodontics, implants, restorations, materials, equipment, and services, making it the only full-chain dental industry cluster in the Yangtze River Delta [3][4] Group 2: Innovation and Collaboration - Continuous innovation is a driving force for industry aggregation, with the park fostering a collaborative ecosystem that aligns clinical needs with research and development [4] - Partnerships with prestigious institutions like Sichuan University and Shanghai Jiao Tong University have led to the establishment of seven innovation platforms, enhancing the effectiveness of R&D by addressing clinical challenges directly [4] Group 3: Ecosystem and Future Goals - The Huishan region aims to integrate medical technology with consumer products, enhancing the value of the industry by developing AI-driven health applications and diagnostic systems [5][6] - A comprehensive ecosystem is being established, including specialized functional areas for R&D, testing, and service, alongside initiatives to attract investment and cultivate talent in the dental industry [6]

新华财经上海1月27日电 "皮肤是抵御外来病原体入侵的第一道防线，是人体的'动态长城'。" "多数情况下，敏感肌都是后天形成的。""修护皮肤屏障不是缺 什么补什么，而是要激活自身修复能力"……日前在玉泽新品发布会上，上海交通大学医学院附属瑞金医院终身教授郑捷、美国加州大学旧金山分校皮肤医 学专家蔄茂强等多位专家学者现场"上课"。专家的讲解，让前沿的皮肤科学理论，不再那么晦涩难懂、遥不可及。同时，医研共创也让这些科研成果从专 利、论文变成市场上的畅销产品。 近年来，医研共创成为国内外化妆品巨头构建差异化优势的战略选择之一。欧莱雅增资制药公司高德美，同年官宣与华山医院共建"皮肤科学实验室"；日妆 巨头资生堂加码中国医美市场，与上海九院等医疗机构展开科研合作；雅诗兰黛集团与嘉会医疗在沪设立联合临床研究中心……一系列动作表明，行业竞争 正从"博流量"转向对基础研究、临床验证和跨学科转化能力的比拼。 "买得起、用得久"饱含医者匠心 "我倡导'健康皮肤、美丽皮肤、健康身体'的理念，皮肤作为人体最大的器官，脱离健康去谈美丽是没意义的。"郑捷说。 美丽建立在健康之上。从医学角度看，维护皮肤屏障的健康对于预防皮肤疾病、保持皮肤 ...

2026年1月20日，玉泽「修屏障 稳到底」新品发布会在金山岭长城脚下举行。在这一承载着中华文明守 护精神的重要地标前，玉泽以"屏障"为核心命题，将皮肤屏障研究、产品创新与文化象征融为一体，完 成了一次兼具科学深度与精神高度的品牌表达。 长城，作为守护疆域与文明的伟大工程，象征着稳固、坚守与延续；皮肤，作为人体最大的器官与第一 道防线，同样承担着抵御外界刺激、维系内在稳定的重要使命。玉泽将新品发布会选址于此，正是希望 通过这一跨越宏观文明与微观生命的隐喻，让"皮肤屏障"这一医学概念，被更直观、更深刻地理解与认 知。 一、玉泽23载笃行医研初心：从"医研长征"到"医研长城" 发布会现场，上海家化董事长兼首席执行官林小海在致辞中表示，长城所代表的守护精神，与上海家化 百余年来始终坚持的匠心与责任高度契合。自1898年创立以来，上海家化始终以匠心为根基，以科研创 新为脉络，守护一代代中国家庭的健康与美丽，而玉泽正是这百年匠心在新时代的延续与创新。 玉泽对皮肤屏障的系统研究始于2003年。彼时，上海家化与上海交通大学医学院附属瑞金医院皮肤科展 开深度医研合作，围绕皮肤屏障这一基础而关键的医学课题持续探索。首款屏障修护 ...

Core Viewpoint - Zhan Yan Biotechnology Co., Ltd. has initiated the listing guidance process to publicly issue shares and list on the Beijing Stock Exchange, aiming to leverage capital market support for sustainable development and increased competitiveness in the beauty industry [2] Company Overview - Zhan Yan Biotechnology was established on December 6, 2019, with a registered capital of 61.62 million yuan, and is led by Zhang Yingting, who holds 62.1551% of the shares [3] - The company specializes in the research, production, and sales of biomedical materials, dermatological skincare products, and biological raw materials, with brands including Zhan Yan and Zhan Xiao Yan [3] - The Zhan Yan brand was launched earlier in 2015, focusing on medical research collaboration, offering products for sensitive skin repair [3] Financial Performance - Projected revenues for Zhan Yan Biotechnology are 486 million yuan and 597 million yuan for 2023 and 2024, respectively, with net profits of approximately 68.48 million yuan and 73.50 million yuan [3] - The gross profit margins are expected to be 62.33% and 68.34% for the same years [3] Market Position and Competition - Zhan Yan's development appears to be lagging behind competitors like Fulejia and Beitaini, which have already established themselves in the capital market and achieved significant revenue growth [4] - Fulejia and Beitaini reported revenues of 1.93 billion yuan and 5.5 billion yuan for 2023, respectively, indicating a strong market presence [4] Strategic Considerations - The company faces challenges in balancing strategic choices and investments between raw material supply and brand products [5] - The competitive landscape includes not only established brands but also new entrants in the medical beauty product segment, increasing market pressure [5] - Zhan Yan's revenue is primarily derived from offline channels, with a significant portion coming from distributors and hospitals, which poses a challenge for transitioning to an online-focused market [5]

Core Insights - The announcement of Zhou Keyu as the skincare ambassador for Winona, a core brand of Betaini Group, reflects a strategic partnership aimed at enhancing professional value and brand image in the sensitive skin care market [1][3] Group 1: Brand and Market Positioning - Winona has been recognized as the top-selling brand in China's sensitive skin care market for five consecutive years (2020-2024), showcasing its strong market presence and professional credibility [4] - The collaboration between Winona and Zhou Keyu is rooted in a shared commitment to professional values, beauty, and health, indicating a long-term strategic vision for Betaini Group [3][4] Group 2: Strategic Development and Ecosystem - Betaini Group is transitioning from a single-brand operation to a multi-brand ecosystem, emphasizing sustainable growth and collaborative synergies among its brands [7][9] - Winona is evolving from a focus on sensitivity repair to a broader range of solutions addressing various sensitive skin needs, which supports the group's ecological expansion and enhances its market offerings [6][9] Group 3: Research and Innovation - Betaini Group's commitment to research and innovation is evident in its high R&D expenditure and the successful registration of new plant-based ingredients, which strengthens its competitive edge in the market [10][13] - The company has established a comprehensive research framework that integrates clinical insights and technological advancements, ensuring the continuous development of unique products [10] Group 4: Sustainability and Social Responsibility - Betaini Group integrates sustainability into its core operations, with initiatives such as ecological restoration in raw material sourcing and a product lifecycle responsibility program [13][15] - The company's long-standing commitment to social responsibility is exemplified by the "We Smile Sunshine Program," which provides skin health services in underserved areas, reinforcing its brand value and market trust [13][15] Group 5: Future Outlook - The strategic focus on building a tightly integrated ecosystem that fosters both internal collaboration and external partnerships is crucial for the long-term viability of Betaini Group [15] - The company's approach to leveraging its professional brand advantages and research capabilities positions it well for sustained growth in the evolving beauty industry [15]

在宁波医美市场愈发追求专业与安心的当下，不少求美者都会悄悄琢磨：宁波美莱怎么样？身边人常提 的美莱医院，到底靠谱吗？毕竟选择医美，安全永远是底线，口碑更是绕不开的考量。不同于单纯罗列 优势的宣传，我们从"医研共创的专业深度"与"用户体验的真实温度"双视角切入，拆解宁波美莱的核心 竞争力，看看"美莱安全吗""美莱口碑怎么样"这些疑问，如何在实际运营中得到解答。 医研背书：资质与技术双重赋能，解答"美莱靠谱吗" 靠谱的医美机构，从来不是靠宣传造势，而是靠实打实的资质与技术说话。美莱深耕医美27年，29城40 院的连锁布局，背后是成熟的医疗管理体系与严苛的合规标准。宁波美莱作为直属机构，不仅持有完整 的《医疗机构执业许可证》，更通过质量管理体系、医学检验室双重认证，从科室设置到人员资质，每 一环都贴合国家医美规范。 2024年的两项行业荣誉，更让"美莱靠谱吗"有了硬核答案。1月，宁波美莱率先成为宁波首家薇旖美人 源化胶原"正品联盟・黑曜机构"。这一被誉为胶原界"金马奖"的认证，从医资、诊疗、服务、口碑多维 度综合评定，全宁波仅1家机构获评，足见其在抗衰领域的专业地位。同一时间，皮肤技术院长刘邦瑜 斩获华东地区"薇旖 ...

Core Viewpoint - The article emphasizes the importance of integrating clinical insights into the skincare industry, highlighting the release of the "2025 China Medical Skincare Clinical Insight Report" as a pivotal moment for bridging the gap between clinical practice and product development [2][3][4]. Summary by Sections Insight Report Overview - The "2025 China Medical Skincare Clinical Insight Report" was launched at the SIA2025 Scientific Skincare Innovation Alliance Annual Conference, marking a significant shift in understanding how dermatologists utilize efficacy skincare products in clinical settings [2][3]. - This report serves as a comprehensive guide for the skincare industry, aiming to eliminate the information barrier between clinical medicine and industry [4]. Methodology and Findings - The report is based on extensive research involving 11,253 dermatologists and 25 industry experts, focusing on five core skin conditions: acne, atopic dermatitis, pigmentary disorders, sensitive skin, and perioperative care in aesthetic medicine [6][8]. - It outlines a full-cycle management approach for skin issues, providing practical guidelines validated by clinical experience [6][14]. Clinical Pathways and Recommendations - The report details specific intervention points for efficacy skincare products throughout the management process of various skin conditions, emphasizing the importance of barrier repair and maintenance in treatment plans [14][15]. - It highlights the necessity of a comprehensive skincare strategy during aesthetic procedures, with 91% of dermatologists recommending a holistic skincare approach [17][19]. Bridging Clinical and Industry Practices - The report translates complex clinical language into actionable insights for product development, addressing the disconnect between medical professionals and the skincare industry [20][21]. - It identifies the role of dermatologists as natural judges of product safety and efficacy, providing a foundation for evidence-based product development [21][22]. Future Opportunities - The report positions dermatologists as key players in the future of skin health management, revealing untapped market potential in the aesthetic medicine sector [23]. - It emphasizes the need for a collaborative approach between clinical insights and product innovation to meet the evolving demands of consumers [24][26].

Core Viewpoint - The beauty industry is transitioning from "concept marketing" to "scientific evidence," with "medical-research collaboration" becoming a key driver for brand upgrades [2][7]. Industry Trends - The SIA Conference 2025, held in Shanghai, focused on the theme "Beauty Across Borders, Professional Without Boundaries," gathering top research institutions, dermatology experts, and leading brands to explore innovative paths and scientific standards in China's skin health industry [3]. - The beauty industry is undergoing a transformation driven by consumer upgrades and the rise of ingredient-focused consumers, with functional skincare growing at ten times the industry average for five consecutive years [7]. - The SIA Conference emphasized the need for brands to rely on professional theories from dermatology and collaborate with authoritative research institutions and clinical experts to effectively translate research into product value [10]. Company Highlights - Fuqing, a brand specializing in precise management of oily and acne-prone skin, showcased its strategic initiatives at the SIA Conference, demonstrating its commitment to "medical-research collaboration" [5][12]. - Fuqing launched a research fund focused on oily and acne-prone skin, aiming to explore the mechanisms of skin issues and develop precise intervention plans in collaboration with universities and research institutions [12][13]. - Fuqing's "Revitalizing Essence" was recognized as a "SIA100 Scientific Product," showcasing its innovative formulation and clinical efficacy, which includes patented technologies and a comprehensive efficacy system [15]. - Fuqing was awarded "China's Dermatology Doctors' Preferred Research Brand," reflecting the trust and endorsement from dermatology professionals, with its products being recommended in over 300 top-tier hospitals and 1,500 secondary hospitals [17]. Future Strategy - Fuqing aims to deepen its "medical-research collaboration" ecosystem by enhancing partnerships with research institutions and clinical experts, accelerating the translation of research results into combined cosmetic and medical products [23]. - The brand plans to leverage big data and skin science to develop more personalized skincare solutions, continuing to iterate on core products like the "Revitalizing Essence" to provide users with the value of scientific skincare [23].

Core Viewpoint - The article emphasizes that while explosive growth has been a hallmark of many brands in the online economy, a sustainable and high-quality slow business model may be the essence of beauty management, as exemplified by the brand Xianse, which focuses on professional products and services rooted in offline channels [2][3]. Group 1: Brand Growth and Recognition - Xianse has maintained rapid growth through a dual-track model involving hospitals and medical beauty institutions, contributing to incremental growth in offline channels [2]. - The brand was awarded the title of "Outstanding Alliance Enterprise" by the Scientific Innovation Alliance and made it to the "Future 100 Skin Health Top 100 Enterprises List" due to its continuous investment in skin health research and collaboration with various sectors [3][4]. Group 2: Research and Development Approach - Xianse's founder, Xue Yonghong, emphasizes that product development is based on real consumer needs rather than trends, focusing on precise targeting of skin issues [7]. - The brand adheres to a "simplified ingredients, targeted precision" philosophy, ensuring that each product contains no more than 10 core ingredients, avoiding ineffective accumulation [8][10]. - Xianse collaborates with top global raw material suppliers and has established joint laboratories with academic institutions to ensure rigorous scientific backing for its products [8][10]. Group 3: Consumer Trust and Product Strategy - Xianse aims to create long-lifecycle products with high repurchase rates, focusing on the effectiveness of products rather than quick sales spikes [12][13]. - The brand's strategy involves precise positioning of products for specific consumer needs, leading to sustainable small hits rather than one-size-fits-all blockbuster products [13][15]. - Recent consumer trials showed a 97.2% satisfaction rate for Xianse products, indicating strong consumer trust and product efficacy [15]. Group 4: Service Model and Training - Xianse has developed a comprehensive service model that integrates face diagnosis, sales processes, and customer care, addressing the operational challenges faced by offline channels [17][20]. - The brand has conducted nearly 100 training sessions for professionals, enhancing their confidence in using Xianse products in clinical settings [20]. - Xianse prioritizes professional knowledge within its team, ensuring that all members are well-versed in skin-related issues and product efficacy [20][21]. Group 5: Long-term Vision and Market Position - Xianse's approach focuses on long-term development rather than chasing market trends, maintaining double-digit growth despite a competitive environment [23]. - The brand's business model, research capabilities, and brand potential have matured, positioning it as a reference for professional brand pathways in offline channels [23].